Entry |
|
Symbol |
GSK3B
|
Name |
(RefSeq) glycogen synthase kinase 3 beta
|
KO |
|
Organism |
csab Chlorocebus sabaeus (green monkey)
|
Pathway |
csab01521 | EGFR tyrosine kinase inhibitor resistance |
csab04550 | Signaling pathways regulating pluripotency of stem cells |
csab04935 | Growth hormone synthesis, secretion and action |
csab05022 | Pathways of neurodegeneration - multiple diseases |
csab05167 | Kaposi sarcoma-associated herpesvirus infection |
|
Brite |
KEGG Orthology (KO) [BR:csab00001]
09130 Environmental Information Processing
09132 Signal transduction
04012 ErbB signaling pathway
103228213 (GSK3B)
04310 Wnt signaling pathway
103228213 (GSK3B)
04340 Hedgehog signaling pathway
103228213 (GSK3B)
04390 Hippo signaling pathway
103228213 (GSK3B)
04151 PI3K-Akt signaling pathway
103228213 (GSK3B)
04150 mTOR signaling pathway
103228213 (GSK3B)
09140 Cellular Processes
09143 Cell growth and death
04110 Cell cycle
103228213 (GSK3B)
09144 Cellular community - eukaryotes
04510 Focal adhesion
103228213 (GSK3B)
04550 Signaling pathways regulating pluripotency of stem cells
103228213 (GSK3B)
09150 Organismal Systems
09151 Immune system
04660 T cell receptor signaling pathway
103228213 (GSK3B)
04657 IL-17 signaling pathway
103228213 (GSK3B)
04662 B cell receptor signaling pathway
103228213 (GSK3B)
04062 Chemokine signaling pathway
103228213 (GSK3B)
09152 Endocrine system
04910 Insulin signaling pathway
103228213 (GSK3B)
04917 Prolactin signaling pathway
103228213 (GSK3B)
04935 Growth hormone synthesis, secretion and action
103228213 (GSK3B)
04919 Thyroid hormone signaling pathway
103228213 (GSK3B)
04916 Melanogenesis
103228213 (GSK3B)
09156 Nervous system
04728 Dopaminergic synapse
103228213 (GSK3B)
04722 Neurotrophin signaling pathway
103228213 (GSK3B)
09158 Development and regeneration
04360 Axon guidance
103228213 (GSK3B)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
103228213 (GSK3B)
09162 Cancer: specific types
05210 Colorectal cancer
103228213 (GSK3B)
05225 Hepatocellular carcinoma
103228213 (GSK3B)
05226 Gastric cancer
103228213 (GSK3B)
05217 Basal cell carcinoma
103228213 (GSK3B)
05215 Prostate cancer
103228213 (GSK3B)
05213 Endometrial cancer
103228213 (GSK3B)
05224 Breast cancer
103228213 (GSK3B)
09172 Infectious disease: viral
05160 Hepatitis C
103228213 (GSK3B)
05162 Measles
103228213 (GSK3B)
05163 Human cytomegalovirus infection
103228213 (GSK3B)
05167 Kaposi sarcoma-associated herpesvirus infection
103228213 (GSK3B)
05165 Human papillomavirus infection
103228213 (GSK3B)
09171 Infectious disease: bacterial
05135 Yersinia infection
103228213 (GSK3B)
09164 Neurodegenerative disease
05010 Alzheimer disease
103228213 (GSK3B)
05020 Prion disease
103228213 (GSK3B)
05022 Pathways of neurodegeneration - multiple diseases
103228213 (GSK3B)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
103228213 (GSK3B)
05415 Diabetic cardiomyopathy
103228213 (GSK3B)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
103228213 (GSK3B)
04932 Non-alcoholic fatty liver disease
103228213 (GSK3B)
04931 Insulin resistance
103228213 (GSK3B)
04934 Cushing syndrome
103228213 (GSK3B)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
103228213 (GSK3B)
09180 Brite Hierarchies
09181 Protein families: metabolism
01001 Protein kinases [BR:csab01001]
103228213 (GSK3B)
09182 Protein families: genetic information processing
03036 Chromosome and associated proteins [BR:csab03036]
103228213 (GSK3B)
Enzymes [BR:csab01000]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.11 Protein-serine/threonine kinases
2.7.11.26 tau-protein kinase
103228213 (GSK3B)
Protein kinases [BR:csab01001]
Serine/threonine kinases: CMGC group
GSK family [OT]
103228213 (GSK3B)
Chromosome and associated proteins [BR:csab03036]
Eukaryotic type
Centrosome formation proteins
Kinases and associated factors
103228213 (GSK3B)
|
SSDB |
|
Motif |
|
Other DBs |
|
LinkDB |
|
Position |
22:60732449..61002735
|
AA seq |
433 aa
MSGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTK
VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSG
EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHR
DIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDV
WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP
WTKDSSGTGHFTSGVRVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN
VKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATAASDANTGDRGQ
TNNAASASASNST |
NT seq |
1302 nt +upstreamnt +downstreamnt
atgtcagggcggcccagaaccacctcctttgcggagagctgcaagccggtgcagcagcct
tcagcttttggcagcatgaaagttagcagagacaaggatggcagcaaggtgaccacagtg
gtggcaactcctgggcagggtccagacaggccacaagaagtcagctatacagacactaaa
gtgattggaaatggatcatttggtgtggtatatcaagccaaactttgtgattcaggagaa
ctggtcgccatcaagaaagtattgcaggacaagagatttaagaaccgagagctccagatc
atgagaaagctagatcactgtaacatagtacgattgcgttatttcttctactccagtggt
gagaagaaagatgaggtctatcttaatctggtgctggactatgttccggaaacagtatac
agagttgccagacactatagtcgagccaaacagacgctccctgtgatttatgtcaagtta
tatatgtatcagctgttccgaagtttagcctatatccattcctttggaatctgccatcgg
gatattaaaccacagaacctcttgttggatcctgatacagccgtattaaaactctgtgac
tttggaagtgcaaagcagctggtccgaggagaacccaatgtttcgtatatctgttctcgg
tactatagggcaccagagttgatctttggagccactgattatacctctagtatagatgta
tggtctgctggctgtgtgttggctgagctgttactaggacaaccaatatttccaggggat
agtggtgtggatcagttggtggaaataatcaaggtcctgggaactccaacaagggagcaa
atcagagaaatgaacccaaactacacagaatttaaattccctcaaattaaggcacatcct
tggactaaggattcgtcaggaacaggacatttcacctcaggagtgcgggtcttccgaccc
cgaactccaccagaggcaattgcactgtgtagccgtctgctggagtatacgccaactgcc
cgactaacaccactggaagcttgtgcacattcattttttgatgaattacgggacccaaat
gtcaaactaccaaatgggcgagacacacctgcactcttcaacttcaccactcaagaactg
tcaagtaatccacctctggctaccatccttattcctcctcatgctcggattcaagcagct
gcttcaacccccacaaatgccacagcagcctcagatgctaatactggagaccgtggacag
accaataatgctgcttctgcatcagcttccaactccacctga |